Similar Items: Heterogeneity of Cancer‐Associated Fibroblasts and Precision Targeting Strategies for Cancer Therapy
- Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution
- Advances in Phase III Clinical Trials and Future Challenges of Targeted Therapy in Advanced Ovarian Cancer
- Endocrine therapy‐induced cancer‐related fatigue in hormone‐dependent malignancies: Mechanisms, impact, and management strategies
- Antidiabetic agents as potential cytotoxic candidates for cancer therapy
- Cancer‐Directed Therapy in the Last Month of Life and Its Association With ICU Utilisation in a Tertiary Care Centre in India
- RNA‐binding protein RBMS1: A new target for cancer diagnosis and treatment